Literature DB >> 31537031

The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review.

Ana Lleo1,2, Patrick S C Leung3, Gideon M Hirschfield4, Eric M Gershwin3.   

Abstract

Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by autoimmune destruction of small to medium size intrahepatic bile ducts. The etiology of PBC remains unknown and pathogenesis features immune-mediated biliary injury, alongside the consequences of chronic cholestasis. PBC is strongly associated with the loss of immune tolerance against mitochondrial antigens and the subsequent presence of an articulated immunologic response that involves both humoral and cellular responses. Both environmental factors and genetic variants increase PBC susceptibility. Biliary epithelial cells have often been considered a passive target of the immune attack in PBC; however, cholangiocyte dedifferentiation, senescence, stress, and deoxyribonucleic acid damage have been recognized to play an active role in the pathogenesis of PBC. This review highlights and discusses the most relevant pathogenetic mechanisms in PBC, focusing on the key factors that lead to the onset of cholestasis and immune activation. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2019        PMID: 31537031     DOI: 10.1055/s-0039-1697617

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  18 in total

Review 1.  Antimitochondrial Antibodies: from Bench to Bedside.

Authors:  Francesca Colapietro; Ana Lleo; Elena Generali
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-29       Impact factor: 10.817

Review 2.  Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics.

Authors:  Ji-Won Park; Jung-Hee Kim; Sung-Eun Kim; Jang Han Jung; Myoung-Kuk Jang; Sang-Hoon Park; Myung-Seok Lee; Hyoung-Su Kim; Ki Tae Suk; Dong Joon Kim
Journal:  Biomedicines       Date:  2022-05-31

Review 3.  How genetic risk contributes to autoimmune liver disease.

Authors:  David Ellinghaus
Journal:  Semin Immunopathol       Date:  2022-06-01       Impact factor: 11.759

Review 4.  Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target.

Authors:  Christy E Trussoni; Steven P O'Hara; Nicholas F LaRusso
Journal:  Semin Immunopathol       Date:  2022-02-17       Impact factor: 11.759

Review 5.  Environmental exposure as a risk-modifying factor in liver diseases: Knowns and unknowns.

Authors:  Juliane I Beier; Gavin E Arteel
Journal:  Acta Pharm Sin B       Date:  2021-09-10       Impact factor: 11.413

6.  Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis: A meta-analysis.

Authors:  Zi-Long Wang; Kai-Min Song; Rui Jin; Yan-Di Xie; Yu-Qiong Wang; Zhi-Cheng Liu; Bo Feng
Journal:  Medicine (Baltimore)       Date:  2022-03-04       Impact factor: 1.817

Review 7.  The Epidemiology of Primary Biliary Cholangitis in European Countries: A Systematic Review and Meta-Analysis.

Authors:  Jakub Gazda; Sylvia Drazilova; Martin Janicko; Peter Jarcuska
Journal:  Can J Gastroenterol Hepatol       Date:  2021-06-19

Review 8.  Current Trends of Essential Trace Elements in Patients with Chronic Liver Diseases.

Authors:  Takashi Himoto; Tsutomu Masaki
Journal:  Nutrients       Date:  2020-07-14       Impact factor: 5.717

9.  Autoimmune diseases - New insights into a troublesome field.

Authors:  Thomas Lung; Benjamin Sakem; Andreas Hemmerle; Michèle Nydegger; Martin Risch; Lorenz Risch; Urs Nydegger
Journal:  J Transl Autoimmun       Date:  2021-06-01

10.  APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.

Authors:  Hong You; Xiong Ma; Cumali Efe; Guiqiang Wang; Sook-Hyang Jeong; Kazumichi Abe; Weijia Duan; Sha Chen; Yuanyuan Kong; Dong Zhang; Lai Wei; Fu-Sheng Wang; Han-Chieh Lin; Jin Mo Yang; Tawesak Tanwandee; Rino A Gani; Diana A Payawal; Barjesh C Sharma; Jinlin Hou; Osamu Yokosuka; A Kadir Dokmeci; Darrell Crawford; Jia-Horng Kao; Teerha Piratvisuth; Dong Jin Suh; Laurentius A Lesmana; Jose Sollano; George Lau; Shiv K Sarin; Masao Omata; Atsushi Tanaka; Jidong Jia
Journal:  Hepatol Int       Date:  2022-02-04       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.